个人简介
EducationPh.D. candidate of Medical Oncology Sun Yat-sen University, Guangzhou, ChinaMaster of Medical Oncology Sun Yat-sen University, Guangzhou, ChinaBachelor of Medicine Henan Medical University, Zhengzhou, ChinaAcademic and Professional Experience2016 to present Adjunct Associate Professor, Faculty of Health Sciences, University of Macau2010 to present Attending Physician, Medical Oncologist,Department of Oncology, Kiang Wu Hospital
近期论文
Representative PublicationsHuang, H., Li, X., Zhu, J., Ye, S., Zhang, H., Wang, W., Wu, X., Peng, J., Xu, B., Lin, Y., Cao, Y., Li, H., Lin, S., Liu, Q. & Lin, T. (2014). Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. JAMA 312, 2521-30. (IF: 30.3)Cao, Y., Xiao, G., Qiu, X., Ye, S. & Lin, T. (2014). Efficacy and safety of crizotinib among Chinese EML4-ALK-positive, advanced-stage non-small cell lung cancer patients. PLoS One 9, e114008. (IF: 3.5)Xiao, G., Cao, Y., Qiu, X., Wang, W. & Wang, Y. (2013). Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. BMC Cancer 13, 226. (IF: 3.3)Huang, Y., Ye, S., Cao, Y., Li, Z., Huang, J., Huang, H., Cai, M., Luo, R. & Lin, T. (2012). Outcome of R-CHOP or CHOP regimen for germinal center and nongerminal center subtypes of diffuse large B-cell lymphoma of Chinese patients. Scientific World Journal 2012, 897178.2. (IF:3.5)Cao, Y., Lan, Y., Qian, J., Zheng, Y., Hong, S., Li, H., Wang, M., Kwak, L. W., Lin, D., Yang, J. & Yi, Q. (2011). Targeting cell surface beta2 -microglobulin by pentameric IgM antibodies. Br J Haematol 154,111-21. (IF: 4.9)Zhai, L., Guo, C., Cao, Y., Xiao, J., Fu, X., Huang, J., Huang, H., Guan, Z. & Lin, T. (2010). Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin’s lymphoma: single center, 15-year experience. Int J Hematol 91, 78-86. (IF: 1.6)Yang, J., Cao, Y., Hong, S., Li, H., Qian, J., Kwak, L. W. & Yi, Q. (2009). Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma. Clin Cancer Res 15, 951-9. (IF: 8.1)
